Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression

血清外泌体 miR-16-5p 通过调节 PD-L1 表达发挥肿瘤抑制剂作用，并成为肺腺癌 PD-L1 抑制剂依赖性免疫治疗的新生物标志物